|
|||||
|
|
The Current Landscape of Immune Checkpoint Blockade in Glioblastoma |
|
| Affiliation: | 1. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Massachusetts General Hospital Cancer Center, 450 Brookline Avenue, Boston, MA 02215-5450, USA;2. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215-5450, USA |
| Abstract: | |
| Keywords: | Glioblastoma (GBM) Immunotherapy Immune checkpoint inhibitor (ICI) Immune checkpoint blockade Programmed cell death receptor 1 (PD-1) Programmed cell death ligand 1 (PD-L1) Cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) |
| 本文献已被 ScienceDirect 等数据库收录！ | |